MPI60
MPI60 is a potent SARS-CoV-2 MPro inhibitor with high antiviral potency, low cellular cytotoxicity, and high in vitro metabolic stability. MPI60 can be used for SARS-CoV-2 research[1].
Product Specifications
CAS Number
[3032440-80-2]
UNSPSC
12352005
Target
SARS-CoV
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/mpi60.html
Purity
89.11
Solubility
10 mM in DMSO
Smiles
O=C(OCC1=CC=CC=C1)N2CC3(CC2C(N[C@@H](C[C@@H]4CCNC4=O)C=O)=O)CCCC3
Molecular Formula
C24H31N3O5
Molecular Weight
441.52
References & Citations
[1]Zhi Zachary Geng, et al. A Systematic Survey of Reversibly Covalent Dipeptidyl Inhibitors of the SARS-CoV-2 Main Protease . bioRxiv. 2023 Jan 18;2023.01.17.524469.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C (Powder, sealed storage, away from moisture)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
GTR15129850 1 Vial
Lentiviral human SLC3A1 shRNA (UAS) - Lentiviral human SLC3A1 shRNA (UAS, GFP) plasmid
Ask
View Details 
